MHCII/B2m-KO(NMG)
Nomenclature
NOD.Cg-PrkdcscidIl2rgem1H2-Ab1em1H2-Aaem1H2-Eb1em1H2-Eb2em1H2-Ea-ps em1B2m em1Smoc
Cat. NO.
NM-NSG-014
Strain State
Repository Live
Model Description
Validation Data
Fig1. Detection of MHCII and B2m expression in spleen in MHCII/B2M-dKO (NMG) mice by RT-PCR.
Fig2. Expression characterization of mouse MHC I and MHC II in MHCII/B2M-dKO (NMG) mice.
Fig3. Hematology of MHCII/B2M-dKO (NMG) mice.
Fig4. Blood biochemistry of MHCII/B2M-dKO (M-NSG) mice.
Fig5. Survival rate of huPBMC-MHCII/B2M-dKO (NMG) mice.
Fig6. GvHD scores of huPBMC-MHCII/B2M-dKO (NMG) mice.
Fig6. Body weight growth curve of huPBMC-MHCII/B2M-dKO (NMG) mice
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more